NCT01209949View on ClinicalTrials.gov

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Acne Vulgaris

Interventions

DRUG

Adapalene 0.1% and Benzoyl Peroxide 2.5% gel

Apply adapalene BPO gel once daily in the evening for 12 weeks

Trial Locations (1)

75006

Thomas J. Stephens and Associates, Carrollton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY